Bliss Kelly 4
4 · Teladoc Health, Inc. · Filed Dec 3, 2025
Insider Transaction Report
Form 4
Bliss Kelly
President, U.S. Group Health
Transactions
- Exercise/Conversion
Common Stock
2025-12-01+1,189→ 56,290 total - Exercise/Conversion
Common Stock
2025-12-01+3,488→ 59,778 total - Exercise/Conversion
Common Stock
2025-12-01+4,858→ 64,636 total - Sale
Common Stock
2025-12-02$7.49/sh−4,582$34,310→ 60,054 total - Exercise/Conversion
Performance Stock Units
2025-12-01−1,189→ 1,186 total→ Common Stock (1,189 underlying) - Exercise/Conversion
Restricted Stock Units
2025-12-01−3,488→ 3,488 total→ Common Stock (3,488 underlying) - Exercise/Conversion
Restricted Stock Units
2025-12-01−4,858→ 24,293 total→ Common Stock (4,858 underlying)
Footnotes (6)
- [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F4]On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F5]On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F6]On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.